Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,161 | 22,045 | 29,725 | 27,896 | 19,266 |
| Marketable Securities | 10,211 | 12,120 | 15,579 | 16,288 | 21,794 |
| Receivables | 17,918 | 18,064 | 18,574 | 7,898 | 24,556 |
| Inventories | 32,179 | 32,496 | 43,414 | 27,164 | 43,354 |
| Other current assets | 0 | 0 | 0 | 36,691 | 0 |
| TOTAL | $89,383 | $88,200 | $111,700 | $120,604 | $116,824 |
| Non-Current Assets | |||||
| PPE Net | 17,709 | 17,256 | 21,042 | 5,689 | 20,998 |
| Investments And Advances | 5,879 | 3,683 | 5,891 | 5,617 | 6,225 |
| Intangibles | 243,156 | 244,066 | 244,976 | 224,300 | 246,805 |
| Other Non-Current Assets | 25,525 | 21,771 | 17,993 | 56,504 | 20,300 |
| TOTAL | $292,269 | $286,776 | $289,902 | $292,110 | $294,328 |
| Total Assets | $381,652 | $374,976 | $401,602 | $412,714 | $411,152 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,231 | 10,614 | 8,619 | 6,285 | 5,034 |
| Accounts payable and accrued liabilities | 3,838 | 4,213 | 4,984 | 2,270 | 11,980 |
| Accrued Expenses | 8,449 | 8,128 | 8,863 | 9,121 | 8,568 |
| Other current liabilities | 4,537 | 5,043 | 13,195 | 4,400 | 13,736 |
| TOTAL | $32,166 | $30,819 | $38,658 | $42,178 | $42,622 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,823 | 10,451 | 15,681 | 24,064 | 20,937 |
| Other Non-Current Liabilities | 15,189 | 11,075 | 12,579 | 8,695 | 14,040 |
| TOTAL | $24,025 | $22,715 | $29,539 | $32,873 | $36,513 |
| Total Liabilities | $56,191 | $53,534 | $68,197 | $75,051 | $79,135 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,387 | 46,138 | 46,031 | 45,300 | 44,031 |
| Common Shares | 46 | 46 | 46 | 45 | 44 |
| Retained earnings | -347,560 | -345,857 | -325,138 | -314,917 | -299,960 |
| Other shareholders' equity | -208 | -555 | -566 | -345 | -660 |
| TOTAL | $325,461 | $321,442 | $333,405 | $337,663 | $332,017 |
| Total Liabilities And Equity | $381,652 | $374,976 | $401,602 | $412,714 | $411,152 |